Nine pharmaceutical companies have managed to boost their earnings recently. However, rising production and operating costs, coupled with various business disruptions, have negatively impacted the financial performance of several firms. Notably, ACI and Silva Pharmaceuticals have seen their losses widen, according to reports from TBS Bangladesh.
